Kimia Biosciences Ltd

Kimia Biosciences Ltd

Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the Unaudited Financial Results (Standalone) for the Second quarter and Half year ended on September 30th, 2026.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has submitted a Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ending September 30, 2026, confirming the acceptance/rejection of securities received for dematerialization and listing on stock exchanges.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about the re-appointment of an Executive Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about the re-appointment of an Executive Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about the change in designation of a Non-Executive Independent Director.

KIMIA BIOSCIENCES LIMITED

Kimia Biosciences Limited has informed about the change in designation of a Non-Executive Independent Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about a change in the designation of a Non-Executive Non-Independent Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about the change in designation of a Non-Executive Independent Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about the change in designation of a Non-Executive Independent Director.

KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED has informed BSE about a change in designation of a Non-Executive Non-Independent Director.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced changes in its board of directors following the approval of its 33rd Annual General Meeting. The company has appointed four new directors, including Mr. Amulya Kumar Nayak, Ms. Reema Goyal, Mr. Avinash Prabhat, and Mr. Sameer Goel, who will retire by rotation.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has declared the results of its remote e-voting and e-voting conducted during the 33rd Annual General Meeting (AGM) held on 28th September, 2026. The company has provided a scrutinizer's report under Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. All resolutions were passed with high voting percentages, with the lowest being 99.9163% for Resolution(2).

Kimia Biosciences Ltd

Kimia Biosciences Ltd has submitted the proceedings of its 33rd Annual General Meeting (AGM) held on September 28, 2026, through video conferencing. The meeting was conducted in accordance with relevant circulars issued by the Ministry of Corporate Affairs and the Securities Exchange Board of India. The AGM approved various resolutions, including the appointment of directors, remuneration of cost auditors, and increasing the borrowing limit.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026, as per SEBI regulations.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the 33rd Annual General Meeting (AGM) to be held on September 28, 2026, through video conferencing. The meeting will discuss the company's financial year 2025-26 annual report and other business matters.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced the outcome of its Board of Directors meeting held on September 3, 2026, where the board considered and approved various matters, including the re-appointment of directors, appointment of new directors, and approval of remuneration for cost auditors and other matters.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has published unaudited financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with a profit of Rs. 35.58 crores and earnings per share of Rs. 0.08.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹2,072.25 crore and profit for the period at ₹35.58 crore.

Kimia Biosciences Ltd

Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve Un-Audited Financial Results for the first quarter ended on June 30th, 2026.